Filing Flows › Tenet Healthcare (THC) › Capital expenditures
Tenet Healthcare (THC) capital expenditures by quarter
Tenet Healthcare's capital expenditures were $198M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 7 quarters it ranged from $168M (Q2 2026) to $364M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $198M | +18% | -29% |
| Q2 2026 | $168M | -7% | -13% |
| Q1 2026 | $180M | -51% | +4% |
| Q4 2025 | $364M | +30% | — |
| Q3 2025 | $280M | +45% | — |
| Q2 2025 | $193M | +12% | — |
| Q1 2025 | $173M | — | — |
Q3 2026 at a glance
Tenet Healthcare, Q3 2026: revenue $5.6B (+6% year over year), operating margin 31.1%, net earnings $1.0B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
Questions
What is Tenet Healthcare's capital expenditures?
Tenet Healthcare's capital expenditures were $198M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has Tenet Healthcare's capital expenditures changed?
Over the last 7 quarters it ranged from $168M (Q2 2026) to $364M (Q4 2025).